- The FDA approved a new drug, Kadcyla, that kills cancer cells more effectively while potentially reducing side effects.
- Men with high-risk prostate cancer undergoing hormone therapy live just as long whether they receive treatment for 18 months or 36 months.
- African-Americans and people living in poverty are more likely to present with an emergency colorectal cancer diagnosis.
- Daily use of a multivitamin reduced total cancer incidence in men tracked for more than a decade.